Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...
Vermont teen Cameron Rider’s preseason football fatigue turned out to be a symptom of mucoepidermoid carcinoma, a rare lung cancer. After months of recurring pneumonia, a bronchoscopy revealed a tumor ...
Lung adenocarcinoma, the most common histological subtype of non‐small cell lung cancer, continues to pose significant challenges in both prognosis and classification. Contemporary research has ...
A new study in The American Journal of Pathology suggests that perilipin 2 could serve as a prognostic factor and points to new potential lipid-based targets for treating lung adenocarcinoma. This ...
Lung adenocarcinoma remains one of the most challenging cancers to diagnose accurately, with pathologists spending countless hours examining tissue samples under microscopes to determine cancer grades ...
Machine Learning–Driven Risk Stratification and Adjuvant Treatment Guidance in Oral Cavity Cancer We analyzed stage I LUAD samples from The Cancer Genome Atlas, Gene Expression Omnibus, and European ...
Final overall survival analysis for a phase 3 randomized trial comparing afatinib to chemotherapy in treatment-naïve non-small cell lung cancer with a sensitizing uncommon epidermal growth factor ...
In a recent study published in Nature Communications, researchers from NYU Langone Health's Perlmutter Cancer Center and the University of Glasgow have developed a cutting-edge AI program capable of ...
Lung cancer in general, and non-small cell lung cancer (NSCLC) in particular, is often asymptomatic in the early stages of the disease. When symptoms do occur in an early stage (e.g., endobronchial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results